Proveca's Series B Round

Proveca raised a round of funding on March 30, 2017.

Proveca is a European pediatric specialty pharmaceutical company developing and licensing off-patent medicines to improve the lives of children in Europe, many of whom have chronic conditions requirin…

Articles about Proveca's Series B Round: